Pentagon wanted to test unregistered medicines on Africans

According to Lieutenant General Igor Kirillov, documents that were found in Ukraine indicate that the Pentagon planned to use the US army to test unregistered medical drugs on the local population and then submit them for approval by supervisory authorities “in the interests of the so-called big pharma,” TASS reported.

“For these ends, it was planned to use its biolaboratories and facilitating agencies, such as Metabiota,” he said.

“Take note of Metabiota’s commercial offer marked ‘confidential,’ which was found among documents at one of the biolaboratories in Ukraine. The offer is addressed to the United States Army Medical Research Institute of Infectious Diseases and concerns training of specialists in infectious diseases in Kenya and Uganda,” Kirillov said.

“The document demonstrates that the Defense Threat Reduction Agency’s (DTRA) and the Department of Homeland Security were involved in the study of pathogens in African countries, while the US Agency for International Development and a number of European Union structures were engaged to make these activities look like ‘humanitarian cooperation,’” he added at a briefing on the analysis of documents concerning the United States’ military biological activities.

Apart from that, in his words, evidence was found showing that Metabiota had been involved in the study of the H7N9 bird flu virus and that it had played a leading role in the implementation of the Predict project for the study of new coronavirus types, under which their carriers – bats – had been caught.

“We have repeatedly pointed to the company’s ties with the son of the US incumbent president, Hunter Biden, and government organizations. Notably, Metabiota’s representatives admit that as a matter of fact they are establishing ties to ensure the Pentagon and other American agencies’ work abroad,” Kirillov added.

He also said that Ukraine’s Science and Technology Center and other Pentagon contractors were taking an active part in these activities.

SKH/PR